US2008287392A1PendingUtilityA1
Wound-Healing Pharmaceutical Compositions in the Form of a Cream Based on Amino Acids and Sodium Hyaluronate
Est. expiryOct 26, 2025(expired)· nominal 20-yr term from priority
Inventors:Franco Conti
A61P 43/00A61P 39/06A61P 17/00A61P 17/02A61K 31/728A61K 31/198A61K 31/401
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to wound-healing pharmaceutical or cosmetic (anti-skin aging) compositions in the form of a cream based on amino acids and sodium hyaluronate.
Claims
exact text as granted — not AI-modified1 - 6 . (canceled)
7 . A pharmaceutical composition in form of a cream, the pharmaceutical composition containing as active ingredient a combination of:
a) glycine and proline; and b) sodium hyaluronate
8 . The pharmaceutical composition of claim 7 , the composition further comprising as active ingredient:
c) lysine and leucine.
9 . The pharmaceutical composition of claim 7 , wherein proline is L-proline, and wherein glycine, L-proline and sodium hyaluronate are comprised within the following percentage ranges by weight:
glycine 0.5 to 2%; L-proline: 0.2 to 1.50%; and sodium hyaluronate: 0.5 to 3%;
10 . The pharmaceutical composition of claim 8 , wherein lysine is L-lysine, leucine is L-leucine, and wherein L-lysine and L-leucine are comprised within the following percentage ranges by weight:
L-lysine hydrochloride: 0.05 to 1%; and L-leucine: 0.05 to 0.3%.
11 . The pharmaceutical composition of claim 7 , wherein proline is L-proline, and wherein glycine, L-proline and sodium hyaluronate have the following percentage ranges by weight:
glycine 1%; L-proline: 0.75%; and sodium hyaluronate: 1.33%;
12 . The pharmaceutical composition of claim 8 , wherein lysine is L-lysine, leucine is L-leucine and wherein L-lysine and L-leucine have the following percentage ranges by weight:
L-lysine hydrochloride 0.1%; and L-leucine: 0.15%.
13 . A method for treating a wound in a biological tissue, the method comprising
administering to the biological tissue a medicament in form of a cream, the medicament comprising a combination of a) glycine and proline; and b) sodium hyaluronate.
14 . The method of claim 13 , wherein the medicament further comprises lysine and leucine.
15 . The method of claim 13 , wherein, the wound is a surgical wound, a vaginal lesion, a rectal lesion, a buccal wound or lesion, a wound from dental surgery, a chronic ulcerous wound, a serious burn, a bedsore or a wound associated with skin aging.
16 . A method to promote regeneration of epithelial cells of a vaginal or rectal tissue, the method comprising
administering to the vaginal or rectal tissue a medicament in form of a cream for vaginal or rectal administration, the medicament comprising a combination of
a) glycine and proline; and
b) sodium hyaluronate.
17 . The method of claim 16 , wherein the medicament further comprises lysine and leucine.
18 . A method to promote regeneration of epithelial cells of a buccal tissue, the method comprising
administering to the buccal tissue a medicament in form of a cream for buccal administration, the medicament comprising a combination of
a) glycine and proline; and
b) sodium hyaluronate.
19 . The method of claim 18 , wherein the medicament further comprises lysine and leucine.Join the waitlist — get patent alerts
Track US2008287392A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.